Articles |
From the Wihuri Research Institute (M.K., P.T.K) and the Department of Forensic Medicine, University of Helsinki (A.P.), Helsinki, Finland.
Correspondence to Petri T. Kovanen, MD, Wihuri Research Institute, Kalliolinnantie 4, 00140 Helsinki, Finland.
Abstract In experimental studies in vitro, mast cells have induced uptake of apolipoprotein B-100 (apoB-100)containing low-density lipoproteins by macrophages, with the subsequent formation of foam cells, the hallmarks of atherosclerosis. Recently, increased numbers of activated, ie, degranulated, mast cells were found to be present in human coronary fatty streaks and atheromas. We therefore sought evidence of a connection between mast cells and foam cell formation in vivo. In electron microscopic studies of human aortic and coronary fatty streaks and atheromas, exocytosed cytoplasmic secretory granules of mast cells were detected in the vicinity of their parent cells. These exocytosed granules had bound apoB-100containing lipoproteins, as indicated by their positive staining with MB 47, a monoclonal antibody against apoB-100. A smooth muscle cell was observed to be in the process of phagocytosing one such exocytosed granule, and in the vicinity of a degranulated mast cell a foam cell contained an ingested mast cell granule. Therefore, the micrographs show that exocytosed granules of intimal mast cells may contribute to intimal foam cell formation and suggest a role for mast cells in human atherogenesis. More generally, the findings provide evidence that phagocytosis of apoB-100carrying particles is one mechanism by which lipoproteins enter human arterial intimal cells.
Key Words: atherosclerosis exocytosis mast cells low-density lipoproteins phagocytosis
This article has been cited by other articles:
![]() |
M. Lee, P. T. Kovanen, G. Tedeschi, E. Oungre, G. Franceschini, and L. Calabresi Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux J. Lipid Res., March 1, 2003; 44(3): 539 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lee, P. Uboldi, D. Giudice, A. L. Catapano, and P. T. Kovanen Identification of domains in apoA-I susceptible to proteolysis by mast cell chymase: implications for HDL function J. Lipid Res., June 1, 2000; 41(6): 975 - 984. [Abstract] [Full Text] |
||||
![]() |
M. Lee, A. von Eckardstein, L. Lindstedt, G. Assmann, and P. T. Kovanen Depletion of Preß1LpA1 and LpA4 Particles by Mast Cell Chymase Reduces Cholesterol Efflux From Macrophage Foam Cells Induced by Plasma Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 1066 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang and P. T. Kovanen Heparin Proteoglycans Released From Rat Serosal Mast Cells Inhibit Proliferation of Rat Aortic Smooth Muscle Cells in Culture Circ. Res., January 22, 1999; 84(1): 74 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Kovanen, M. Manttari, T. Palosuo, V. Manninen, and K. Aho Prediction of Myocardial Infarction in Dyslipidemic Men by Elevated Levels of Immunoglobulin Classes A, E, and G, but Not M Arch Intern Med, July 13, 1998; 158(13): 1434 - 1439. [Abstract] [Full Text] |
||||
![]() |
H. Nagoshi, Y. Uehara, F. Kanai, S. Maeda, T. Ogura, A. Goto, T. Toyo-oka, H. Esumi, T. Shimizu, and M. Omata Prostaglandin D2 Inhibits Inducible Nitric Oxide Synthase Expression in Rat Vascular Smooth Muscle Cells Circ. Res., February 9, 1998; 82(2): 204 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Pentikainen, E. M. P. Lehtonen, K. Oorni, S. Lusa, P. Somerharju, M. Jauhiainen, and P. T. Kovanen Human Arterial Proteoglycans Increase the Rate of Proteolytic Fusion of Low Density Lipoprotein Particles J. Biol. Chem., October 3, 1997; 272(40): 25283 - 25288. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Liao, M. Rudling, and B. Angelin Novel Effects of Histamine on Lipoprotein Metabolism: Suppression of Hepatic Low Density Lipoprotein Receptor Expression and Reduction of Plasma High Density Lipoprotein Cholesterol in the Rat Endocrinology, May 1, 1997; 138(5): 1863 - 1870. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |